Evidence map›Paper›PMID 20408697›Full record

ArticleBiointerphases2008

Nanoparticle diffraction gratings for DNA detection on photopatterned glass substrates.

Iuliana E Sendroiu, Robert M Corn

Abstract read
In one paragraph

Article in Biointerphases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Silica nanowire arrays for diffraction-based bioaffinity sensing.Chemistry (Weinheim an der Bergstrasse, Germany) · 2014
    Article
  3. Nanostructured Substrates for Optical Sensing.The journal of physical chemistry letters · 2011
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Iuliana E SendroiuDepartment of Chemistry, University of California-Irvine, Irvine, California 92697, USA.
Robert M Corn

Funding

SPR IMAGING STUDIES OF PROTEIN/DNA INTERACTIONSR01GM059622 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI CORN, ROBERT M · 1999 to 2018
$5.1M
Development of SPR/MS protein array platformR21RR018475 · NCRR · INTRINSIC BIOPROBES, INC. · PI NEDELKOV, DOBRIN · 2005 to 2005
$147k
NCRR NIH HHS 1R21 RR018475-01A2NCRR NIH HHS R21 RR018475NIGMS NIH HHS 2R01 GM059622-04NIGMS NIH HHS R01 GM059622
6 · The paper itself

Abstract

An ex situ nanoparticle DNA detection assay utilizing DNA-modified nanoparticles attached to DNA monolayer gratings on glass substrates is developed. The assay utilizes the simultaneous hybridization of a single stranded DNA (ssDNA) target molecule to both an amine-modified DNA oligonucleotide attached to an amine-reactive glass surface and a thiol-modified DNA oligonucleotide attached to a 13 nm gold nanoparticle. Surface plasmon resonance imaging measurements are used to characterize the two sequential hybridization adsorption processes employed in the assay, and fluorescence microscopy is used to characterize the formation of DNA monolayer gratings via the photopatterning of the amine-reactive glass slides. First order diffraction measurements utilizing incoherent collimated white light source and a 10 nm bandpass filter centered at 600 nm provided quantitative measurements of target ssDNA down to a concentration of 10 pM. Fourth order diffraction measurements employing a HeNe laser and avalanche photodiode were used to detect target ssDNA adsorption from 10 microl of a solution with a concentration as low as 10 fM, corresponding to 60,000 target DNA molecules. This simple yet sensitive grating-based nanoparticle DNA detection assay should be directly applicable for genetic screening, mRNA expression assays, and microRNA profiling.

Identifiers

PMID20408697
PMCPMC2860185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.